Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insurance savings "strengthen system":

This article was originally published in Clinica

Executive Summary

German health minister Ulla Schmidt said that the Euro4bn ($4.7bn) surplus achieved by the statutory sickness finds last year was a tribute to the system's new efficiency since the health reform of early 2004. The associated savings of Euro9-10bn also meant that decision-makers could build more quality into the system. Additionally, it meant that average public contributions to the funds did not have to increase. They are currently at 14.2%. Ms Schmidt had earlier talked of a rise to some 15%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel